← Browse by Condition
Medical Condition
alopecia areata
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 3, Phase 2, EARLY_Phase 1
ClinicalMetric tracks all active clinical trials for alopecia areata sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — alopecia areata Clinical Trials
How many clinical trials are currently recruiting for alopecia areata?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for alopecia areata, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for alopecia areata?
alopecia areata research spans Phase 1 (1 trial), Phase 2 (3 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a alopecia areata clinical trial?
Eligibility criteria for alopecia areata trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 3
Phase 3 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06012240 Phase 3
Recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Enrollment
1,500 pts
Location
United States, Argen...
Sponsor
AbbVie
NCT06327581
Recruiting
Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata
Enrollment
88 pts
Location
Egypt
Sponsor
Zagazig University
NCT06104839 Phase 2
Recruiting
Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata
Enrollment
73 pts
Location
South Korea
Sponsor
NEXTGEN Bioscience
NCT06564805
Recruiting
Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata
Enrollment
30 pts
Location
Mexico
Sponsor
Universidad Autonoma de Nuevo ...
NCT07242638 Phase 2
Recruiting
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Enrollment
56 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo...
NCT06531109
Recruiting
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Enrollment
850 pts
Location
United States, China...
Sponsor
Pfizer
NCT05398809 Phase 2
Recruiting
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
Enrollment
70 pts
Location
United States
Sponsor
National Institute of Allergy ...
NCT07029204 EARLY_Phase 1
Recruiting
Intralesional Cyclosporine for Alopecia Areata
Enrollment
12 pts
Location
United States
Sponsor
University of California, Davi...
NCT07136467
Recruiting
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
Enrollment
2,795 pts
Location
Argentina, Canada, C...
Sponsor
AbbVie
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology